409
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Guillain-Barré syndrome in ulcerative colitis and SARS-CoV-2 infection: a case report and literature review

ORCID Icon, , , , , , & show all
Article: FSO913 | Received 02 Jul 2023, Accepted 03 Oct 2023, Published online: 20 May 2024

References

  • Ousseiran ZH, Fares Y, Chamoun WT. Neurological manifestations of COVID-19: a systematic review and detailed comprehension. Int. J. Neurosci. 133(7), 754–769 (2021).
  • Palaiodimou L, Stefanou M-I, Katsanos AH et al. Prevalence, clinical characteristics and outcomes of Guillain-Barré syndrome spectrum associated with COVID-19: a systematic review and meta-analysis. Eur. J. Neurol. 28(10), 3517–3529 (2021).
  • Bentley SA, Ahmad S, Kobeissy FH, Toklu HZ. Concomitant Guillain-Barré syndrome and COVID-19: a meta-analysis of cases. Medicina (Kaunas) 58(12), 1835 (2022).
  • Mahmoud H, Alhathla A, El-Fiky A et al. Incidence of Guillain-Barré Syndrome post COVID-19: a systematic review of case reports and case series. Eur. Rev. Med. Pharmacol. Sci. 27(5), 2152–2164 (2023).
  • Qorchi H, Kissani N, Chraa M. Concomitant Guillain-Barré syndrome and cerebral venous thrombosis complicating a SARS-CoV-2 infection: a case report. Pan. Afr. Med. J. 42, 212 (2022).
  • Zito A, Alfonsi E, Franciotta D et al. COVID-19 and Guillain-Barré syndrome: a case report and review of literature. Front. Neurol. 11, 909 (2020).
  • Ferro JM, Oliveira Santos M. Neurology of inflammatory bowel disease. J. Neurol. Sci. 424, 117426 (2021).
  • Nielsen HL, Dalager-Pedersen M, Nielsen H. Risk of inflammatory bowel disease after Campylobacter jejuni and Campylobacter concisus infection: a population-based cohort study. Scand. J. Gastroenterol. 54(3), 265–272 (2019).
  • Kalischuk LD, Buret AG. A role for Campylobacter jejuni-induced enteritis in inflammatory bowel disease? Am. J. Physiol. Gastrointest. Liver Physiol. 298(1), G1–G9 (2010).
  • Finsterer J. Triggers of Guillain-Barré syndrome: Campylobacter jejuni predominates. Int. J. Mol. Sci. 23(22), 14222 (2022).
  • de la Torre RG, Morís G, Martínez DP, Montes IC. Guillain-Barré syndrome, tuberculosis and inflammatory bowel disease: a multiple association. Int. Arch. Med. 3, 15 (2010).
  • Zimmerman J, Steiner I, Gavish D, Argov Z. Guillain-Barré syndrome: a possible extraintestinal manifestation of ulcerative colitis. J. Clin. Gastroenterol. 7(4), 301–303 (1985).
  • Krystallis CS, Kamberoglou DK, Cheilakos GB, Maltezou MN, Tzias VD. Guillain-Barré syndrome during a relapse of ulcerative colitis: a case report. Inflamm Bowel Dis. 16(4), 555–556 (2010).
  • Liu Z, Zhou K, Tian S, Dong W. Ulcerative colitis with Guillain-Barré syndrome: a case report. Medicine (Baltimore) 97(25), e11013 (2018).
  • Saito M, Hozumi I, Kawakami A, Tsuji S. A case of post-rubella Guillain-Barré syndrome associated with ulcerative colitis. Rinsho Shinkeigaku 34(11), 1121–1124 (1994).
  • Roca B, Moreno I, Meneu E. Ulcerative colitis and acquired demyelinating neuropathy (Guillain-Barré syndrome). Neth. J. Med. 54(3), 129–130 (1999).
  • Tominaga K, Tsuchiya A, Sato H et al. Co-existent ulcerative colitis and Guillain-Barré syndrome: a case report and literature review. Clin. J. Gastroenterol. 12(3), 243–246 (2019).
  • Bouchra A, Benbouazza K, Hajjaj-Hassouni N. Guillain-Barre in a patient with ankylosing spondylitis secondary to ulcerative colitis on infliximab therapy. Clin. Rheumatol. 28(1), 53–55 (2009).
  • Jayasundara JMHD, Samarawickrama VT, Peiris R, Aponso T, Abeynayake D. Concomitant Guillain-Barré Syndrome in a young Sri Lankan male with severe ulcerative colitis. BMC Gastroenterol. 22(1), 411 (2022).